Search for: "BRISTOL-MYERS SQUIBB COMPANY"
Results 81 - 100
of 468
Sort by Relevance
|
Sort by Date
29 May 2019, 3:34 am
Colombia--The Superintendency of Industry and Commerce has granted registration of the mark “VERSACLOX” (here), on behalf of Bioquimico Pharma S.A.; the trademark was previously owned by BRISTOL MYERS SQUIBB COMPANY but it lapsed in 1982. [read post]
29 Apr 2019, 3:00 am
” Wellington, in a rare public rebuke this year, said it opposed Bristol-Myers Squibb Co. [read post]
24 Apr 2019, 3:00 am
In late February, Wellington, which runs $359 billion for Vanguard, announced it would oppose Bristol-Myers Squibb ’s plan to acquire Celgene. [read post]
8 Apr 2019, 9:59 pm
Increases were notanle for Bristol Myers-Squibb and Takeda, while Sanofi and Gilead showed reduced sales. [read post]
30 Mar 2019, 8:49 pm
Neal Dahiya of Bristol-Myers Squibb Company; Michael Flibbert of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Michael Rosato of Wilson Sonsini Goodrich & Rosati will also address strategies for obtaining, and opposing, appellate standing. [read post]
11 Mar 2019, 1:03 pm
Supreme Court established limitations on personal jurisdiction over non-resident corporate defendants in state court “mass” actions in Bristol-Myers Squibb Co. v. [read post]
11 Mar 2019, 10:15 am
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019) followed suit and unanimously affirmed snap removal as a procedural vehicle to remove to federal court. [read post]
12 Feb 2019, 7:56 pm
Bristol-Myers Squibb Co. [read post]
9 Feb 2019, 9:50 pm
Gene Quinn of IPWatchdog and Kevin Noonan of Patent Docs will take a look at the recently announced merger between Bristol-Myers Squibb and Celgene, including what the combined company will look like from a patent perspective, and what competition regulators are likely to be interested in questioning about this acquisition. [read post]
5 Feb 2019, 7:34 am
Chairman Chuck Grassley and Ranking Member Ron Wyden sent the invitations to AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Pfizer and Sanofi. [read post]
29 Jan 2019, 3:12 pm
Several large cases account for much of this effect, including the cases filed against Johnson & Johnson, Facebood, NVIDIA, Bristol-Myers Squibb and Celgene. [read post]
25 Jan 2019, 12:00 am
The first being Bristol Myers Squibb Co’s (BMY) acquisition of Celgene Corp. [read post]
22 Jan 2019, 2:09 am
One case, Bristol-Myers Squibb Co. v. [read post]
18 Dec 2018, 3:16 pm
Therefore, under the Supreme Court’s rulings in Daimler and Bristol-Myers Squibb, the defendant could be subject to personal jurisdiction in Massachusetts only if the conduct forming the basis for a plaintiff’s claim occurred in Massachusetts. [read post]
27 Oct 2018, 10:58 am
Bristol-Myers Squibb, Co. [read post]
28 Aug 2018, 12:16 am
Although fact-specific, this case sets a threshold as to actions which would not constitute the repackaging of products (whilst Bristol-Myers Squibb and Boehringer Ingelheim set out actions which would). [read post]
23 Aug 2018, 3:00 am
The court provided a detailed summary of the current status of the law pertaining to personal jurisdiction based upon a review of several notable United States Supreme Court Opinions, the most recent of which was in the case of Bristol-Myers Squibb Co. v. [read post]
12 Jun 2018, 6:56 am
The agency’s argument that the regulation leaves the decision up to the employer was unavailing, the court explained, under the competitor standing doctrine and had already been rejected in earlier cases, such as Bristol-Myers Squibb Co. v. [read post]
11 Jun 2018, 8:00 am
Supreme Court in Bristol-Myers Squibb rejected such an argument. [read post]
9 Jun 2018, 8:58 pm
Paul Golian of Bristol-Myers Squibb Company, Ali Salimi of the U.S. [read post]
